When.com Web Search

  1. Ads

    related to: paclitaxel cost per dose of kevzara 2 days years

Search results

  1. Results From The WOW.Com Content Network
  2. Sarilumab - Wikipedia

    en.wikipedia.org/wiki/Sarilumab

    Sarilumab, sold under the brand name Kevzara, is a human monoclonal antibody medication against the interleukin-6 receptor. [6] Regeneron Pharmaceuticals and Sanofi developed the drug for the treatment of rheumatoid arthritis (RA), for which it received US FDA approval on 22 May 2017 and European Medicines Agency approval on 23 June 2017.

  3. Paclitaxel - Wikipedia

    en.wikipedia.org/wiki/Paclitaxel

    Paclitaxel, sold under the brand name Taxol among others, is a chemotherapy medication used to treat ovarian cancer, esophageal cancer, breast cancer, lung cancer, Kaposi's sarcoma, cervical cancer, and pancreatic cancer. [11]

  4. Dose-dense chemotherapy - Wikipedia

    en.wikipedia.org/wiki/Dose-dense_chemotherapy

    For example, in standard treatment of ovarian cancer, paclitaxel is given at 175 mg/m 2 body surface every three weeks. In dose dense therapy paclitaxel is given at 50–80 mg/m 2 every week (150–240 mg/m 2 in 3-weeks). [2]

  5. Mitotic inhibitor - Wikipedia

    en.wikipedia.org/wiki/Mitotic_inhibitor

    Similarly replacement of the acetyl group at C-16 with L-trp-OC 2 H 5, d-Ala(P)-(OC 2 H 5) 2, L-Ala(P)-(OC 2 H 5) 2 and I-Vla(P)-(OC 2 H 5) 2 gave rise to new analogues having anti- tubulin activity. Also it was found that the vindoline's indole methyl group is a useful position to functionalize potentially and develop new, potent vinblastine ...

  6. Chemotherapy - Wikipedia

    en.wikipedia.org/wiki/Chemotherapy

    In the same study, investigators compared the incidence of common 5-FU-associated grade 3/4 toxicities between the dose-adjusted people and people dosed per BSA. [23] The incidence of debilitating grades of diarrhea was reduced from 18% in the BSA-dosed group to 4% in the dose-adjusted group and serious hematologic side effects were eliminated ...

  7. Protein-bound paclitaxel - Wikipedia

    en.wikipedia.org/wiki/Protein-bound_paclitaxel

    In 2014, Abraxane's sales were $848 million, 31 percent year-over-year increase. [18] The UK's National Institute for Health and Care Excellence (NICE) announced in 2015, that it would not support the routine use of protein-bound paclitaxel in advanced pancreatic cancer on the NHS. [19] However, this decision was changed in September 2017. [20]

  1. Ads

    related to: paclitaxel cost per dose of kevzara 2 days years